1. Home
  2. DK vs MNKD Comparison

DK vs MNKD Comparison

Compare DK & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$34.30

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.67

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DK
MNKD
Founded
2001
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
DK
MNKD
Price
$34.30
$5.67
Analyst Decision
Hold
Strong Buy
Analyst Count
17
6
Target Price
$35.41
$10.08
AVG Volume (30 Days)
1.5M
3.9M
Earning Date
02-27-2026
02-23-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
23.47
EPS
N/A
0.10
Revenue
$10,667,200,000.00
$313,787,000.00
Revenue This Year
N/A
$21.29
Revenue Next Year
N/A
$25.53
P/E Ratio
N/A
$57.51
Revenue Growth
N/A
17.43
52 Week Low
$11.03
$3.38
52 Week High
$43.50
$6.51

Technical Indicators

Market Signals
Indicator
DK
MNKD
Relative Strength Index (RSI) 57.24 47.64
Support Level $32.29 $5.54
Resistance Level $34.95 $6.05
Average True Range (ATR) 1.64 0.29
MACD 0.49 -0.02
Stochastic Oscillator 68.57 25.88

Price Performance

Historical Comparison
DK
MNKD

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: